JAZZ Jazz Pharmaceuticals

For the fiscal year ended 31/12/2022: Jazz Pharmaceuticals's revenues increased by 18.26% and amounted to 3.66B. Net income increased by 32.03% to -224.06M. Net assets decreased by 22.18% to 3.09B and EPS increased from -5.52 to -3.58.